Copertina

Dihydropyrimidine dehydrogenase deficiency as a cause of fatal 5-Fluorouracil toxicity

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	Shiraz S. Fidai
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Hospital Universitário da Universidade de São Paulo 2018
Soggetti:	Medicina Drug Fluorouracil Pancytopenia Genetic Testing Dihydropyrimidine Dehydrogenase Deficiency
Accesso online:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Hemophagocytic lymphohistiocytosis presenting as acute coronary syndrome
di: Gabriel Melki
Pubblicazione: (2021)

Autopsy findings of acute erythroid leukemia
di: Mayur Parkhi
Pubblicazione: (2023)

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients
di: Rafael Caparica
Pubblicazione: (2019)

Viscometric investigations and molecular interactions of some derivatives of 5-substituted indole dihydropyrimidines in mixed organic solvents
di: L. C. Heda
Pubblicazione: (2010)

Co-occurrence of myeloid neoplasm and plasma cell neoplasm
di: Husam Jum’ah
Pubblicazione: (2022)

FeC19 cage vehicle for fluorouracil anticancer drug delivery: DFT approach
di: Dhumad, Adil Muala, et al.
Pubblicazione: (2021)

Unexpected Diversity in Gene Clusters Encoding Formate Hydrogenlyase Complex Machinery in Vibrionaceae Correlated to Fermentative Hydrogen Production.
di: Sawabe, Tomoo, et al.
Pubblicazione: (2025)

Crp and Arc system directly regulate the transcription of NADH dehydrogenase genes in nitrate and nitrite respiration.
di: Liu, Jia-Rong, et al.
Pubblicazione: (2025)

Integrating incompatible tandem photobiocatalysis in artificial cells enables metabolic modulation of natural cells.
di: Wang, Zhicheng, et al.
Pubblicazione: (2025)

Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer.
di: Mzoughi, Slim, et al.
Pubblicazione: (2025)

Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model.
di: Gao, Xiaoxiang, et al.
Pubblicazione: (2024)

Patient-derived organoids predict chemotherapy response of locally advanced gastric cancer.
di: Huang, Miao, et al.
Pubblicazione: (2026)

Lipidome plasticity in medium- and long-chain fatty acid oxidation disorders: Insights from dried blood spot lipidomics.
di: Guerra, Inês M S, et al.
Pubblicazione: (2025)

Identification and Structural Elucidation of a New Synthetic Cannabinoid, MDMB‐5′Br‐PINACA, in Seized Herbal Materials
di: Alexandre Barcia de Godoi, et al.
Pubblicazione: (2025)

The origin of 2,5‐dimethoxy‐4‐methylamphetamine (DOM, STP)
di: Keeper Trout, et al.
Pubblicazione: (2024)

Identification of Metabolites of the Dietary Supplement Ingredient 5α‐Hydroxy‐Laxogenin
di: Daniel Derwand, et al.
Pubblicazione: (2026)

In vitro metabolism study of ADB‐P‐5Br‐INACA and ADB‐4en‐P‐5Br‐INACA using human hepatocytes, liver microsomes, and in‐house synthesized references
di: Tobias Rautio, et al.
Pubblicazione: (2024)

In Vivo and In Vitro Evaluation of PTeCA (1H‐Pyrrole‐2,3,4,5‐Tetracarboxylic Acid) in Hair Matrix as a Marker for Oxidative Cosmetic Treatment
di: Sara Casati, et al.
Pubblicazione: (2026)

Soil microbial response to glucose and phosphorus addition under agricultural systems in the Brazilian Cerrado
di: ADÃO S. FERREIRA
Pubblicazione: (2013)

Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
di: Zhongquan Li, et al.
Pubblicazione: (2025)

Development of 3β,4α‐dihydroxy‐5α‐androstan‐17‐one standard solution for doping analyses
di: Miho Kuroe, et al.
Pubblicazione: (2024)

Synthesis, structural characterization, analytical profiling, and application to authentic samples of synthesized Phase I metabolites of the synthetic cannabinoid 5F‐MDMB‐PICA
di: Rui‐Jia Chen, et al.
Pubblicazione: (2024)

Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine
di: Marianne Skov‐Skov Bergh, et al.
Pubblicazione: (2024)

Screening and Quantification of the Synthetic Cannabinoid Receptor Agonist 5F‐MDMB‐PINACA From Seized Prison Paper Using Ultraperformance Liquid Chromatography–Mass Spectrometry Approaches
di: Giorgia Vaccaro, et al.
Pubblicazione: (2025)

A “Pheraplex” Capsule Labeled as Desoxymethyltestosterone From the Market Turned Out to Be 17,17‐Dimethyl‐18‐nor‐5α‐androst‐13‐en‐3β‐ol
di: Sisi Zhu, et al.
Pubblicazione: (2025)

Interest of hair tests to discriminate a tail end of a doping regimen from a meat contamination in case of challenging an antidoping rule violation. III. Case report involving boldenone
di: Pascal Kintz, et al.
Pubblicazione: (2024)

Interest of Hair Tests to Discriminate a Tail End of a Voluntary Doping Regimen From the Use of a Contaminated Medicine in Case of Challenging an Antidoping Rule Violation. VI. Case Example With Trimetazidine
di: Pascal Kintz, et al.
Pubblicazione: (2024)

Interest of hair tests to discriminate a tail end of a doping regimen from a drug transfer between two individuals in case of challenging an anti‐doping rule violation. IV. Case example with mesterolone
di: Pascal Kintz, et al.
Pubblicazione: (2024)

Hair analysis in postmortem investigations: Case of a skeletonized body
di: Anne‐Laure Pelissier‐Alicot, et al.
Pubblicazione: (2024)

LC‐IRMS: Towards a High‐Throughput IRMS Methodology?
di: Michaël Polet, et al.
Pubblicazione: (2025)

Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers
di: Carmel Heiland, et al.
Pubblicazione: (2025)

Segmental Hair Analysis of Diphenhydramine and Cyclizine Following a Single Dose
di: Jan Bílek, et al.
Pubblicazione: (2026)

Human phase‐I metabolism of three synthetic cannabinoids bearing a cumyl moiety and a cyclobutyl methyl or norbornyl methyl tail: Cumyl‐CBMEGACLONE, Cumyl‐NBMEGACLONE, and Cumyl‐NBMINACA
di: Arianna Giorgetti, et al.
Pubblicazione: (2024)

An Improved GC–MS/MS Method for a Fast Multidrug Analysis in Hair
di: HuiFen Hannah Zhang, et al.
Pubblicazione: (2024)

Ethylated Phosphorylcholine as a New Marker for Alcohol Consumption: A Proof of Concept
di: Catalina Dumitrascu, et al.
Pubblicazione: (2025)

PEth Cut‐Off Thresholds for Hazardous Alcohol Consumption Based on a Drinking Study
di: Lisa Walther, et al.
Pubblicazione: (2025)

Fentanyl and Propofol Misuse: Hair Analysis Provides Significant Evidence in the Death of a Young Doctor
di: M. José Burgueño, et al.
Pubblicazione: (2025)

Detection of a Distinct Erythropoietin (EPO) Profile After Isoelectric Focusing in Patients With Familial Erythrocytosis
di: Laurent Martin, et al.
Pubblicazione: (2026)

Evaluation of Diagnostic Sensitivity and Specificity of a New Automatized Assay for Indirect Synthetic Urine Identification
di: Laura Franke, et al.
Pubblicazione: (2025)

Chemical Straightening as a Source of Analytical Variability in Hair Testing: A Dual‐Analyte Case Report
di: Miriam Blanco‐Ces, et al.
Pubblicazione: (2026)